198 related articles for article (PubMed ID: 32244387)
41. Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline.
Sullivan JR; Lupien A; Kalthoff E; Hamela C; Taylor L; Munro KA; Schmeing TM; Kremer L; Behr MA
PLoS Pathog; 2021 Oct; 17(10):e1009965. PubMed ID: 34637487
[TBL] [Abstract][Full Text] [Related]
42. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF
Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819
[TBL] [Abstract][Full Text] [Related]
43. Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus.
Chen Y; Chen J; Zhang S; Shi W; Zhang W; Zhu M; Zhang Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712660
[No Abstract] [Full Text] [Related]
44. Antimicrobial peptides against drug resistant Mycobacterium abscessus.
da Silva JL; Gupta S; Olivier KN; Zelazny AM
Res Microbiol; 2020; 171(5-6):211-214. PubMed ID: 32198075
[TBL] [Abstract][Full Text] [Related]
45. Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus.
Madani A; Mallick I; Guy A; Crauste C; Durand T; Fourquet P; Audebert S; Camoin L; Canaan S; Cavalier JF
PLoS One; 2020; 15(9):e0238178. PubMed ID: 32946441
[TBL] [Abstract][Full Text] [Related]
46. Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
Schäfle D; Selchow P; Borer B; Meuli M; Rominski A; Schulthess B; Sander P
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318008
[No Abstract] [Full Text] [Related]
47. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049
[No Abstract] [Full Text] [Related]
48. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
Pryjma M; Burian J; Kuchinski K; Thompson CJ
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379
[TBL] [Abstract][Full Text] [Related]
49.
Shoen C; Benaroch D; Sklaney M; Cynamon M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
[TBL] [Abstract][Full Text] [Related]
50. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus.
Malin JJ; Winter S; van Gumpel E; Plum G; Rybniker J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427298
[No Abstract] [Full Text] [Related]
51. Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the
Zheng H; Liu D; Lu J; Song Y; Wang S; Zhao Y; Ni X
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397054
[TBL] [Abstract][Full Text] [Related]
52.
Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
[TBL] [Abstract][Full Text] [Related]
53.
Recchia D; Stelitano G; Stamilla A; Gutierrez DL; Degiacomi G; Chiarelli LR; Pasca MR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902066
[No Abstract] [Full Text] [Related]
54. Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Ma Z; Lynch AS
J Med Chem; 2016 Jul; 59(14):6645-57. PubMed ID: 27336583
[TBL] [Abstract][Full Text] [Related]
55. High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.
Rudra P; Hurst-Hess K; Lappierre P; Ghosh P
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632012
[TBL] [Abstract][Full Text] [Related]
56.
Le Run E; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
[TBL] [Abstract][Full Text] [Related]
57. Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery.
Richter A; Strauch A; Chao J; Ko M; Av-Gay Y
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012760
[No Abstract] [Full Text] [Related]
58. Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.
Hurst-Hess KR; Saxena A; Rudra P; Yang Y; Ghosh P
Mol Cell; 2022 Sep; 82(17):3166-3177.e5. PubMed ID: 35905736
[TBL] [Abstract][Full Text] [Related]
59. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
60. Differential
Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
